An overview of a new study in adults showing the Abrysvo respiratory syncytial virus (RSV) vaccine preventing lower respiratory tract disease (LRTD) caused by RSV infection among older adults, a group at high risk of severe disease.
https://virologydownunder.com/a-good-news-rsv-vaccine-story-for-adults/